Correlation Between Larimar Therapeutics and Enliven Therapeutics
Can any of the company-specific risk be diversified away by investing in both Larimar Therapeutics and Enliven Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Larimar Therapeutics and Enliven Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Larimar Therapeutics and Enliven Therapeutics, you can compare the effects of market volatilities on Larimar Therapeutics and Enliven Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Larimar Therapeutics with a short position of Enliven Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Larimar Therapeutics and Enliven Therapeutics.
Diversification Opportunities for Larimar Therapeutics and Enliven Therapeutics
0.89 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between Larimar and Enliven is 0.89. Overlapping area represents the amount of risk that can be diversified away by holding Larimar Therapeutics and Enliven Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enliven Therapeutics and Larimar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Larimar Therapeutics are associated (or correlated) with Enliven Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enliven Therapeutics has no effect on the direction of Larimar Therapeutics i.e., Larimar Therapeutics and Enliven Therapeutics go up and down completely randomly.
Pair Corralation between Larimar Therapeutics and Enliven Therapeutics
Given the investment horizon of 90 days Larimar Therapeutics is expected to generate 1.0 times more return on investment than Enliven Therapeutics. However, Larimar Therapeutics is 1.0 times less risky than Enliven Therapeutics. It trades about -0.03 of its potential returns per unit of risk. Enliven Therapeutics is currently generating about -0.09 per unit of risk. If you would invest 401.00 in Larimar Therapeutics on November 3, 2024 and sell it today you would lose (17.00) from holding Larimar Therapeutics or give up 4.24% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Larimar Therapeutics vs. Enliven Therapeutics
Performance |
| Timeline |
| Larimar Therapeutics |
| Enliven Therapeutics |
Larimar Therapeutics and Enliven Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Larimar Therapeutics and Enliven Therapeutics
The main advantage of trading using opposite Larimar Therapeutics and Enliven Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Larimar Therapeutics position performs unexpectedly, Enliven Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enliven Therapeutics will offset losses from the drop in Enliven Therapeutics' long position.| Larimar Therapeutics vs. Vaxcyte | Larimar Therapeutics vs. Syndax Pharmaceuticals | Larimar Therapeutics vs. Merus BV | Larimar Therapeutics vs. Sutro Biopharma |
| Enliven Therapeutics vs. Pmv Pharmaceuticals | Enliven Therapeutics vs. Cullinan Oncology LLC | Enliven Therapeutics vs. Immuneering Corp | Enliven Therapeutics vs. Aerovate Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |